Tafamidis
Catalog No: 193182
CAS Number: 594839-88-0
Purity: >98%
Tafamidis, Tafamidis, also known as Fx-1006 or PF-06291826, is a drug for the amelioration of transthyretin-related hereditary amyloidosis (also familial amyloid polyneuropathy, or FAP), a rare but deadly neurodegenerative disease.
For research use only. We do not sell to patients.
Chemical Information
| Name | Tafamidis |
|---|---|
| Iupac Chemical Name | 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylic acid |
| Synonyms | Fx-1006, Fx1006, Fx 1006, Fx-1006A, PF-06291826, PF06291826, PF 06291826, Tafamidis, Vyndaqel |
| Molecular Formula | C14H7Cl2NO3 |
| Molecular Weight | 308.114 |
| Smile | O=C(C1=CC=C2N=C(C3=CC(Cl)=CC(Cl)=C3)OC2=C1)O |
| InChiKey | TXEIIPDJKFWEEC-UHFFFAOYSA-N |
| InChi | InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19) |
| CAS Number | 594839-88-0 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | >98% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
